
ECMO in Sickle Cell Disease: Outcomes and Evidence Gaps
A systematic review examines ECMO in sickle cell disease, highlighting uncertain mortality estimates, complication reporting gaps, and implications for perfusion teams.
Explore articles, research, and perspectives from the International Perfusion Association.

A systematic review examines ECMO in sickle cell disease, highlighting uncertain mortality estimates, complication reporting gaps, and implications for perfusion teams.

A review of vasoactive support during VA-ECMO examines ventricular loading, mixed shock, drug selection, and the limits of current outcome evidence.

A regional systematic review examines mortality, serious bleeding, and duration of ECMO support in adults with COVID-19, with very low-certainty evidence limiting comparisons across

A systematic review finds substantial bloodstream-infection burden during adult ECMO, but wide variation and very low-certainty evidence limit conclusions about prevalence and infection-attributable mortality.

In the 24-patient randomized HERACLES trial, IABP improved a measured myocardial oxygen supply-demand ratio during VA-ECMO, while Impella CP did not. The acute physiological

A systematic review examines mortality, intensive care recovery, and staged palliation after neonatal Norwood ECMO, with important limits on causal interpretation.

A national Medicare study shows rising ECMO use in infarct-related cardiogenic shock and explains why claims-based mortality comparisons cannot establish treatment effects.

A case report describes VA-ECMO and Impella support after suspected medication-related cardiac arrest during treatment for neurosyphilis-associated super-refractory status epilepticus. Combined circulatory support and

A survey of 83 pediatric ECMO nurses examines how perceived knowledge, autonomy, and teamwork relate to reported care activities—and what perfusion teams can learn.

A randomized trial of 30 residents found no significant difference in simulated VA-ECMO cannulation time or overall procedural quality after a procedural workshop versus

The ECSTATIC feasibility trial compared platelet transfusion triggers of 50 and 90 × 10⁹/L in 50 children on ECMO, supporting a larger definitive trial.

A 57-patient study compares Impella and selective biatrial drainage during VA-ECMO, with differences in bleeding and transfusion but no established survival benefit.
This site is protected by reCAPTCHA.
IPA COMMUNITY POLL
Loading poll…